Evidence map›Paper›PMID 27198062›Full record

ArticleScientific reports2016

Novel positive allosteric modulators of GABAA receptors with anesthetic activity.

Maria C Maldifassi, Roland Baur, David Pierce, Anahita Nourmahnad, Stuart A Forman, Erwin Sigel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Allosteric crosstalk in modular proteins: Function fine-tuning and drug design.Computational and structural biotechnology journal · 2023
    Review
  5. High-Dose Benzodiazepines Positively Modulate GABAInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maria C MaldifassiInstitute of Biochemistry and Molecular Medicine, University of Bern, CH-3012 Bern, Switzerland.
Roland BaurInstitute of Biochemistry and Molecular Medicine, University of Bern, CH-3012 Bern, Switzerland.
David PierceDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, 02114 Massachusetts.
Anahita NourmahnadDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, 02114 Massachusetts.
Stuart A FormanDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, 02114 Massachusetts.
Erwin SigelInstitute of Biochemistry and Molecular Medicine, University of Bern, CH-3012 Bern, Switzerland.
Massachusetts General Hospital · USUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABAA receptors are the main inhibitory neurotransmitter receptors in the brain and are targets for numerous clinically important drugs such as benzodiazepines, anxiolytics and anesthetics. We previously identified novel ligands of the classical benzodiazepine binding pocket in α1β2γ2 GABAA receptors using an experiment-guided virtual screening (EGVS) method. This screen also identified novel ligands for intramembrane low affinity diazepam site(s). In the current study we have further characterized compounds 31 and 132 identified with EGVS as well as 4-O-methylhonokiol. We investigated the site of action of these compounds in α1β2γ2 GABAA receptors expressed in Xenopus laevis oocytes using voltage-clamp electrophysiology combined with a benzodiazepine site antagonist and transmembrane domain mutations. All three compounds act mainly through the two β+/α- subunit transmembrane interfaces of the GABAA receptors. We then used concatenated receptors to dissect the involvement of individual β+/α- interfaces. We further demonstrated that these compounds have anesthetic activity in a small aquatic animal model, Xenopus laevis tadpoles. The newly identified compounds may serve as scaffolds for the development of novel anesthetics.

Indexed as

Allosteric RegulationAnestheticsAnimalsBenzodiazepinesComputer SimulationDrug Evaluation, PreclinicalFlumazenilLigandsMolecular StructurePatch-Clamp TechniquesReceptors, GABA-AXenopus laevisXenopus ProteinsAnestheticsBenzodiazepinesFlumazenilLigandsReceptors, GABA-AXenopus Proteins

Identifiers

PMID27198062
PMCPMC4873749
OpenAlexW2396532571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.